Nature's Sunshine Products, Inc. (NATR) is a Lehi, Utah-based maker and seller of herbal and nutritional supplements and personal care products, distributed largely through a global network of independent consultants. The stock carries limited sell-side coverage: two current analyst price targets were reviewed, and both are $25, producing an arithmetic mean — and therefore central target — of $25.
Canaccord Genuity's Susan Anderson reiterated a Buy and lowered the target to $25 from $36 in late October 2026. D.A. Davidson's Brian Holland reiterated a Buy with a $25 target in August 2026, down from $33. The analyst range is therefore narrow at $25 to $25, a reflection of the sharp downward revisions rather than genuine agreement among many firms. Both analysts remain constructive but are modeling meaningfully lower near-term growth after a guidance reduction. These figures are individual published targets, not an official published consensus.
The stock last traded near $12.02, close to its 52-week low of about $11.93 and far below its 52-week high of $28.14. Reaching $25 would require a gain of roughly 108%, a very large move by any standard and one that implies a more-than-doubling of the share price from current levels.
The path to that outcome would likely need to be built on restored top-line growth and a re-rating of the stock's valuation. NATR trades at a trailing P/E (price-to-earnings ratio) near 12 and a forward P/E near 11, with an EV/EBITDA (enterprise value to earnings before interest, taxes, depreciation, and amortization) of roughly 3.5, suggesting the market is pricing in limited near-term momentum. A sustained return to revenue growth, particularly outside China, and evidence that margin expansion is durable would be central to any re-rating.
NATR is trading near the bottom of its 52-week range of roughly $11.93 to $28.14. The 50-day moving average sits near $13, and the 200-day moving average is around $20.50, meaning the stock remains in a longer-term downtrend and would need to reclaim both levels on the way toward $25. The $11.93 area is a key support level to watch, while the prior $17–$20 zone — where the stock consolidated before its second-quarter selloff — may act as resistance on any recovery. Short interest of about 5% of shares outstanding adds a modest potential catalyst in either direction.
Analyst price targets typically reflect a roughly 12-month research horizon, though the specific horizon for these $25 targets was not disclosed. The most immediate item to watch is the company's third-quarter earnings report, scheduled for November 4, 2026, along with any update to full-year guidance. Investors should also monitor China sales trends, foreign-exchange effects, gross margin progression, operating cash flow, and any analyst target revisions or rating changes after results.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and spot shifting trends more efficiently than manual scanning allows. For those following NATR or the broader consumer staples space, the signals offer a complementary, data-driven way to track evolving momentum.
Can NATR reach $25? The central $25 target — the mean of two current Buy-rated analyst targets — sits about 108% above the latest price near $12.02, making the required move very large. The bull case rests on a clean balance sheet, strong gross margins, digital expansion, and a long-term plan to roughly double sales. The bear case is grounded in a China sales decline, a reduced 2026 outlook, an earnings miss, and negative near-term operating cash flow. With only two analysts covering the stock and both having just cut their targets, the $25 figure should be read as a directional view rather than a precision forecast. The upcoming quarterly report and any guidance revision are the clearest near-term signals of whether the stock can begin closing that wide gap.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that NATR and BGS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NATR and BGS's prices will move in lockstep.
| Ticker / NAME | Correlation To NATR | 1D Price Change % | ||
|---|---|---|---|---|
| NATR | 100% | +1.38% | ||
| BGS - NATR | 28% Poorly correlated | +6.40% | ||
| JBSS - NATR | 28% Poorly correlated | +3.93% | ||
| CENTA - NATR | 27% Poorly correlated | +1.84% | ||
| CENT - NATR | 25% Poorly correlated | +1.80% | ||
| LSF - NATR | 25% Poorly correlated | +11.26% | ||
More | ||||
| Ticker / NAME | Correlation To NATR | 1D Price Change % |
|---|---|---|
| NATR | 100% | +1.38% |
| Food: Major Diversified industry (62 stocks) | 22% Poorly correlated | +3.82% |